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Abstract: Valuable information concerning stability of compounds can be obtained 
by using different media (water, hydrochloric acid or sodium hydroxide) for dissolution of 
active pharmaceutical substances. Furthermore, additional knowledge is gained by perfor-
ming experiments at different temperatures. This research paper deals with the stability of 
amlodipine besylate and bisoprolol fumarate in different media at different temperatures, 
whereby certain conclusions are drawn. For stability assessment, chemical kinetics appro-
ach was used, and constant rate (k), half-time (t1/2) and activation energy (Ea) were used for 
prediction of compound stability degree. The stability of amlodipine besylate and bisopro-
lol fumarate were tested, both separately and in mixture, in water and in 0.01M HCl. All the 
investigated solutions were treated at two temperatures 25° and 70°C at the following time 
intervals: 0, 1 h, 24 h, 48 h and 72 h. Hydrophilic Interaction Liquid Chromatography – 
HILIC method, previously developed and validated, was used. On the basis of obtained 
results it was concluded that amlodipine-besylate was more stable in water than in acid 
medium, more stable in mixture rather than individually and more stable at lower tempera-
tures.  
This was confirmed by the obtained values of monitored parameters: amlodipine 
besylate Ea = 30.68 kJ mol-1, k (25 °C) = 0.000333 mM h-1, k (70 °C) = 0.00169 mM h-1; 
amlodipine besylate in mixture Ea = 42,414 kJ mol-1, k (25 °C) = 1.27·10-4 mM h-1,  
k (70 °C) = 0.0012 mM h-1. Based on the obtained approximate Ea value for bisoprolol 
fumarate in acid (59 kJ mol-1) and in water (56 kJ mol-1), bisoprolol fumarate showed 
excellent stability against the media in which it was studied. On the other hand, the tempe-
rature had a significant effect on the stability of bisoprolol fumarate. These results provide 
the relevant information about the stability of the tested active substances, and may be of 
importance during the development of an appropriate pharmaceutical product. A bigger 
influence on the stability of bisoprolol fumarate had a temperature effect. 
Keywords: amlodipine besylate, bisoprolol fumarate, stability in solutions, chemical 
kinetics.  
 
 
 
 1. INTRODUCTION 
 
Water has a very wide application in pharma-
ceutical practice. Water is used as an excipient in 
final product, in production of active pharmaceutical 
ingredients, for cleaning/laundry equipment and 
containers [1] and finally water is an excellent sol-
vent. Water's ability to dissolve a large number of 
substances lays in its physicochemical properties: 
small molecular volume (which allows easy penetra-
tion into the crystal lattice of substances), a powerful 
permanent dipole, ability to form hydrogen bonds 
and high dielectric constant [2]. Water is official by 
the European Pharmacopoeia of 2011. (Ph. Eur. 7.0), 
containing the following monographs for water: 
Purified Water – Aqua purificata, Highly Purified 
Water – Aqua valde purificata, Water for Injections 
– Aqua ad iniectabile [3] and water for dilution of 
concentrated solution for hemodialysis [2]. Potable 
water serves as a raw material for preparation of all 
these official water types. Potable water is usually 
subjected to distillation processes, ion exchange 
(exchange ions/demineralization), reverse osmosis 
and ultrafiltration. Water must have appropriate 
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physicochemical values and microbiological para-
meters (conductivity, total organic carbon, microbial 
contamination, nitrates, heavy metals, aluminum, 
bacterial endotoxins) that correspond to Ph. Eur. 7.0 
regulations. In addition, limits for acidity, alkalinity, 
chlorides, sulfates, ammonium, calcium, magnesi-
um, oxidizable substances, residue after evaporation 
and bacterial contamination are specified as well [2]. 
Water also affects the stability of drugs. The chemi-
cal stability of a drug is of great importance, since it 
becomes less effective as it undergoes degradation. 
Also, drug decomposition may yield some side-
effects with products that are harmful for the patient. 
In modern pharmaceutical analysis, stability studies 
of pharmacodynamic active substances are of great 
importance. Stability is quantitatively expressed as 
the expiration date of the drug, i.e. as the time during 
the drug stay suitable for use if kept under proper 
defined conditions. The importance of stability is 
highlighted by regulations prescribed by the Euro-
pean Medicines Agency (EMA) and International 
Conference of Harmonization (ICH) [4,5].  
Chemical kinetics has a very wide application 
in the study of the stability of pharmaceutical prepara-
tions since stability depends on degradation rate of 
active substances [6]. Hydrolysis of the drug entity 
can be a major factor in the instability of solutions. 
So, in order to design stable products, we must first 
understand how our product degrades. Temperature is 
one of the primary factors affecting drug stability [7].  
Temperature is an important parameter becau-
se most reactions proceed faster at elevated tempera-
tures in comparison with lower temperatures. By 
performing forced degradation studies at elevated 
temperatures, also known as accelerated stability 
studies, one can predict the stability of compounds. 
In accelerated stability testing, a product is stressed 
at several high (warmer than ambient) temperatures 
and the amount of heat input required to cause pro-
duct failure is determined [8]. This is done to subject 
the product to a condition that accelerates degrada-
tion. This information is then projected to predict the 
shelf life or used to compare the relative stability of 
alternative formulations. This usually provides an 
early indication of the product shelf life and thus 
shortening the development schedule [9,10]. 
The concept of accelerated stability testing is 
based upon the Arrhenius equation, as shown in 
equation 1. 
k = Ae-Ea/RT                               (1) 
k – rate constant 
Ea – activation energy, J mol-1 
A – the frequency factor, s-1 
R –  universal gas constant, 8.314 J mol-1 K-1 
 
Ea is used as a measure of temperature depen-
dence of the rate constant. Ea values of about  
40–130 kJ mol-1 are generally observed in the degra-
dation of drug substances. The term Ea is a measure 
of how sensitive the degradation rate of a drug is to 
temperature changes. Estimation of rate constant for 
drug degradation is an important step in predicting 
the stability of pharmaceuticals. Knowing how such 
rate constant changes with temperature in a 
quantitative way may allow predicting the stability 
at other temperatures.  
The aim of this paper is to investigate the 
stability of amlodipine besylate (AB) and bisoprolol 
fumarate (BF) individually and in mixtures influenced 
by different media: water (H2O) and hydrochloric 
acid (HCl), and at different temperatures (25 °C and 
70 °C). As mentioned above, kinetics parameters give 
very valuable information concerning stability. In 
order to estimate the stability of AB and BF systems, 
the following kinetics parameters were monitored: 
rate constant (k), half-time reactions (t1/2) and the 
activation energy (Ea). The tested analytes (AB and 
BF) are official in Ph. Eur. 7.0 which provides a met-
hod for determination of both compounds and their 
related substances – Reverse Phase High Performance 
Liquid Chromatography method (RP–HPLC), column 
C18 (250 x 4.6 mm, 5 µm particle size), with isocratic 
elution method for AB and a gradient elution method 
for BF [3]. Chemical structure of analyzed compo-
unds is shown in Figure 1.  
After reviewing literature it was shown that 
AB and BF were determined in pharmaceutical 
dosage forms mostly using the RP–HPLC on a C18 
column [11,12]. Also, the combination of HPLC 
method and spectrophotometric method was used 
to determine BF in combination with metoprolol 
and hydrochlorothiazide from biological materials 
using HPLC and spectrophotometric methods 
[13−15] as well as to determine AB from tablets 
and biological material in combination with lisino-
pril, losartan, hydrochlorothiazide, metoprolol, 
olmesartan or other antihypertensive drugs 
[16−21]. L. Kristoffersen et al. described a method 
for simultaneous determination of BF and other 
beta-blockers from biological material by high 
pressure liquid chromatography in combination 
with mass spectrometry [22]. There are numerous 
papers about determination of BF and other beta-
blockers, either alone or in mixture with ranitidine, 
omeprazole, citalopram or other drugs by using 
Hydrophilic Interaction Liquid Chromatography 
(HILIC) method [23−26]. 
Concerning literature, it was concluded that 
there were no stability studies of AB and BF degrada-
tion performed by HILIC method. Also, there is no 
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literature data concerning chemical degradation kine-
tics on these two analytes (both individually and in 
mixtures) with different medium and different tempe-
ratures. This research paper will provide very valua-
ble information regarding stability of these two very 
important active substances and may be of great help 
during development of appropriate pharmaceutical 
products. 
 
 
Figure 1. Chemical structure of analyzed compounds 
 
 
2. METHODS AND MATERIALS  
 
Chromatographic system. The experiments 
were performed on chromatographic system Agilent 
Technologies HP 1200, which consists of the HP 
1200 pump, HP 1200 UV/VIS detector and Chem-
Station Software, Origin and Windows XP for col-
lection and data analysis 
Other equipment and accessories. pH meter 
Cyberscan pH 11 (Eutech, Malaysia), a magnetic 
stirrer (Falco, Italy), a system for filtering water 
(Whatman, Germany), ultrasonic bath (Bandelin, 
Sonorex digitec, Germany), Incubators I (Instrumen-
taria ST-05, Croatia), Incubator II (Binder, 
Germany). Method: Hydrophilic Interaction Liquid 
Chromatography (HILIC), previously developed and 
validated 
Reagents. Acetonitrile (Fisher Scientific, 
England), Acetic acid (Lachner, Czech Republic), 
All reagents were of the HPLC grade.  
HPLC water quality obtained by system Barn-
stead, distilled water obtained by system Barnstead 
and ammonium acetate (Lachner, Czech Republic) 
Standards. Bisoprolol fumarate and Amlodi-
pine besylate (working standards). 
Solutions. Basic solutions of amlodipine 
besylate and bisoprolol fumarate (c = 1 mg mL-1) 
were prepared in acetonitrile. Working solutions of 
amlodipine besylate and bisoprolol fumarate 
 (c = 100 mg ml-1) were prepared by dissolving in 
water and 0.01M HCl.  
Chromatographic conditions. Column – Luna 
5 µ HILIC 200A (100 mm x 4.6 mm, 5 µm particle 
size), mobile phase is a mixture of acetonitrile–water 
solution of 10 mM ammonium acetate (pH 4.0 adju-
sted by concentrated acetic acid) at the ratio of  
92:8 V/V. The flow rate was 1 mL min-1 and column 
temperature was 30 oC. UV detection was carried 
out at 230 nm and injection volume was 20 µL. 
3. RESULTS AND DISCUSSION 
 
Reference chromatogram of tested analytes AB 
and BF is presented in Figure 2. Reference chromato-
gram consists of two chromatographic peaks, one for 
BF (Area 2537.32 mAU min-1, corresponding to the 
concentration of 0.1304 mM L-1) and for AB (Area 
2533.5 mAU min-1, corresponding to the concentra-
tion of 0.1763 mM L -1). By changing experimental 
conditions (solvent and temperature), we were able to 
monitor the process of degradation of AB and BF 
through the change in peaks surface which is propor-
tional to concentration. We have monitored changes 
of peak area at the following time intervals: 0, 1, 24, 
48 and 72 h. For simplicity and better presentation 
only results for two time intervals (1 h and 72 h) were 
presented. Well defined peaks were chosen.   
 
a) Amlodipine besylate and Bisoprolol fuma-
rate degradation – individually 
 
Tables 1−3 below present parameters of 
degradation process of AB and BF in water and 
hydrochloric acid at 25° and 70 °C. Under every 
table there is an appropriate chromatogram that 
reflects the data presented in tables. 
The data presented in Table 1 and Table 2 
showed that the degradation process of AB is very 
much influenced by the temperature and the media. 
The degradation process that is conducted at elevated 
temperature (70 °C) and in acid media is more prono-
unced, leaving AB rather unstable under these 
experimental conditions (Figure 3 and Figure 4). BF, 
on the other hand, is quite stable in water despite hig-
her temperature, since chromatogram (Figure 5) 
showed almost no change in peak surface. Degradation 
of BF is more affected by hydrochloric acid, as seen in 
Table 3 and Figure 6. Figure 6 also showed that as a 
result of BF degradation under acid influence, impurity 
peak appeared at 4.042 min retention time. 
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Figure 2. Chromatogram obtained under optimum chromatographic conditions 
 
Table 1. Degradation of AB in the water at 25 °C and at 70 °C 
Time for degradation 1 h 72 h 
Temperature 25 °C 
Peak Area (mAU min-1) 2 442.41 2 270.02 
Concentration (mM L-1) 0.17 0.158 
Degradation (%) 3,59 10,4 
Temperature 70 °C 
Peak Area (mAU min-1) 2 413.68 1 479.82 
Concentration (mM L-1) 0.168 0.103 
Degradation (%) 4,73 41,59 
 
Table 2. Degradation of AB in the 0,01M HCl at 25 °C and at 70 °C 
Time for degradation 1 h 72 h 
Temperature 25 °C 
Peak Area (mAU min-1) 2 356.16 1 982.72 
Concentration (mM L-1) 0.164 0.138 
Degradation (%) 7  21.74 
Temperature 70 °C 
Peak Area (mAU min-1) 2 413.67 732.7 
Concentration (mM L-1) 0.168 0.051 
Degradation (%) 4,73 71.08 
 
Table 3. Degradation of BF in the 0,01M HCl at 25 °C and at 70 °C 
Time for degradation 1 h 72 h 
Temperature 25 °C 
Peak Area (mAU min-1) 2 393.33 2 159.84 
Concentration (mM L-1) 0.123 0.111 
Degradation (%) 5,68 14.88 
Temperature 70 °C 
Peak Area (mAU min-1) 2 303.11 175.12 
Concentration (mM L-1) 0.118 0.009 
Degradation (%) 9,23 93.1 
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Figure 3. Degradation of AB in water at 25 °C and at 70 °C 
 
 
Figure 4. Degradation of AB in HCl at 25 °C and at 70 °C 
 
 
Figure 5. Degradation of BF in water at 25 °C and at 70 °C 
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Figure 6. Degradation of BF in HCl at 25 °C and at 70 °C  
  
 
b) Amlodipine besylate and Bisoprolol fuma-
rate degradation – mixture 
 
AB and BF were examined in a mixture, 
under the same conditions, in order to determine the-
ir mutual influence on stability. In Figure 7A it can 
be seen that in aqueous medium at 25 °C there was 
no significant change in size of the observed peaks. 
The peak area of BF remained unchanged, while AB 
in mixture showed greater stability, i.e. the area of 
its peak for 72 h was reduced by a total of 7 %                
(2 356.21 mAU min-1, i.e. c = 0.164 mM L-1). 
At the temperature of 70 °C for 72 h, BF 
degraded only by 2.7 % (2 468.81 mAU min-1, i.e.  
c = 0.126 mM L-1), while the degradation of AB was 
26.71 % (1 856.8 mAU min-1, i.e. c = 0.129 mM L-1) 
(Figure 7B). It can be concluded that the compounds 
are more stable in an aqueous medium in the 
mixture, rather than individually, even at high tem-
perature. It can be assumed that AB and BF, when 
contained in a mixture, increase stability with each 
other in an aqueous medium, even at elevated tem-
perature. 
By observing the chromatogram of BF and 
AB in 0.01M HCl (Figure 8), it can be seen that both 
compounds are also more stable in the mixture rat-
her than individually. Figure 8A shows the change 
of surface of tested analytes after 1 h, 24 h and 72 h.  
For total 72 hours the degradation of AB is 
10.4 % (2 270.02 mAU min-1, i.e. c = 0.158 mM L-1), 
and BF is 11,04 % (2 257.2 mAU min-1, i.e.  
c = 0.116 mM L-1).  
Figure 8B shows the change at 70 °C the 
degradation of both compounds is significant, for 
AB, for 72 hours degradation it is 51.8 % 
(1 221.15 mAU min-1, i.e. c = 0.085 mM L-1), while 
for BF in 72 h the degradation is 79.29 %  
(525.48 mAU min-1, i.e. c = 0.027 mM L-1).  
It is evident from Figure 8B that BF and AB 
are degraded in a high percentage. There are impuri-
ties at the retention time of 4,04 minutes which sur-
face increases with time. This impurity was produ-
ced during the degradation of BF, as it can be seen 
in Figure 6B and Figure 8B.  
Having reviewed stability and degradation of 
AB and BF systems from chromatograms under dif-
ferent experimental conditions, the obtained concen-
tration in a proper time interval were further subjec-
ted to calculation in order to get certain kinetics 
parameters that could confirm our previously stated 
conclusions. 
In Table 4 to Table 7 all the relevant kinetics 
parameters for stability study of AB and BF are 
summarized. The values for constant rate, half-time 
and activation energy for AB (Table 4 and Table 5) 
and BF (Table 6 and Table 7) degradation at 25 °C 
and 70 °C, both, in water and 0,01M hydrochloric 
acid are presented. From the obtained results it can 
be confirmed, once again, that the medium and tem-
perature have a great impact on degradation of sub-
stances being analyzed. It should be mentioned that 
Ea for BF and AB alone in water is not presented in 
Tables 4 and 6 due to BF having constant rate equal 
to zero, while AB showed mixture kinetics.  
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Figure 7. Degradation of mixtures BF and AB in water at 25 °C and 70 °C 
 
 
Figure 8. Degradation of mixtures BF and AB in 0,01 M HCl at 25 °C and 72 °C 
 
 
 
Table 4. Kinetics parameter of AB in water 
Parameter 25 °C 70 °C 
k 1,875·10-4 mM h-1 5,163·10-2 mM-1h-1 
n Zero order kinetics Second order kinetics 
t1/2 460 h 117,76 h 
 
Table 5. Kinetics parameter of AB in HCl 
Parameter 25 °C 70 °C 
k 3,33·10-4 mM h-1 1,69·10-3 mM h-1 
n Zero order kinetics Zero order kinetics 
t1/2 246 h 50 h 
Ea 30,68 kJ mol-1 
 
Table 6. Kinetics parameter of BF in water 
Parameter 25 °C 70 °C 
k 0 2,6·10-3 mM-1 h-1 
n - Second order kinetics 
t1/2 0 2999 h 
 
Table 7. Kinetics parameter of BF in HCl 
Parameter 25 °C 70 °C 
k 1,634 · 10-3 h-1 3,707· 10-2 h-1  
n First order kinetics First order kinetics 
t1/2 425 h 18 h 
Ea 59,03 kJ mol-1 
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Table 8. Kinetics parameter of mixture of AB and BF in water 
Parameter AB BF 25 °C 70 °C 25 °C 70 °C 
k 2,6·10-3 mM-1 h-1 2,56·10-2 mM-1 h-1 0 9·10-4 mM-1 h-1 
n Second order kinetics Second order kinetics - Second order kinetics 
t1/2 2270,92 h 236,42 h 0 8812,11 h 
Ea 43,218 kJ mol-1 - 
 
Table 9. Kinetics parameter of mixture of AB and BF in HCl 
Parameter 
AB BF 
25 °C 70 °C 25 °C 70 °C 
k 1,272·10-4 mM h-1 1,2·10-3 mM h-1 1,13·10-3 h-1 2,196·10-2 h-1 
n Zero order kinetics Zero order kinetics First order kinetics First order kinetics 
t1/2 661 h 71 h 613 h 32 h 
Ea 42,4146 kJ mol-1 56,062 kJ mol-1 
 
 
AB in HCl follows the zero order reaction, 
while BF follows the first order reaction at 25° and  
70 °C (Table 5 and Table 7). This different type of 
reactions affects half-time of the substance. The con-
cept of half-time is very important, since it plays a 
key role in determining how quickly a drug decreases 
after being absorbed. Generally, the half-life of zero 
order reaction decreases as the concentration decrea-
ses and it is dependent on the amount of initial con-
centration and constant rate, while the half-time of 
first order is practically independent of initial concen-
tration. Half-time values reflect the statement concer-
ning greater stability of AB and BF in mixture than 
individually. Temperature effect was quite as 
expected; higher temperatures gave higher values of 
constant rate, which confirms the hypothesis that 
degradation of AB and BF is faster. This trend was 
kept in AB and BF mixture too. The degradation of 
AB in the mixture happened faster than the degrada-
tion of BF in the mixture (Table 8 and Table 9). One 
should notice that BF was much more stable in HCl 
than AB since the value of Ea for BF (59.03 kJ mol-1) 
(Table 7) had almost twice of Ea value for AB  
(30.68 kJ mol-1) (Table 5). Furthermore, if we compa-
re Ea results obtained for AB and BF, individually 
and in the mixture, such a great stability of BF was 
observed in each case, since activation energy of BF 
individually (59.03 kJ mol-1) and in the mixture 
(56.06 kJ mol-1) (Table 9) did not significantly chan-
ge. Probably we could gain more information on BF 
stability in a more aggressive media.   
 
 
4. CONCLUSION 
 
We can conclude that the proposed HILIC 
method is applicable to the stability study of AB and 
BF, individually and in mixture. Upon analysing the 
data from the kinetics point of view we gained some 
valuable information and we can conclude as 
follows: the choice of solvents and elevated tempe-
ratures have impact on stability of AB and BF, more 
aggressive solvents and elevated temperatures con-
tribute to a greater level of degradation, BF is more 
stable than AB, AB and BF in mixture stabilize each 
other making AB and BF more stable in mixture 
than alone which was confirmed by kinetics parame-
ters.  
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ИСПИТИВАЊЕ СТАБИЛНОСТИ АМЛОДИПИН-БЕСИЛАТА И  
БИСОПРОЛОЛ-ФУМАРАТА У ВОДЕНИМ РАСТВОРИМА 
 
Сажетак: Коришћењем различитих медијума (вода, хлороводонична киселина 
или натријум-хидроксид) за растварање активних фармацеутских супстанци, може се 
добити доста корисних информација о стабилности испитиваних једињења. Поред 
тога, додатна знања стичу се извођењем експеримената на различитим температура-
ма. У овом раду описано је испитивање стабилности амлодипин-бесилата и бисопро-
лол-фумарата у различитим медијумима при различитим температурама и изведени 
су закључци о њиховој стабилности. 
За проучавање стабилности примијењена је хемијска кинетика, а параметри 
који су коришћени за предвиђање степена стабилности испитиваних једињења су 
константа брзине реакције (к), полувријеме распада (t1/2) и енергија активације (Еа). 
Стабилност амлодипин-бесилата и бисопролол-фумарата испитана је у води и 0,01 М 
HCl при чему је праћена њихова стабилност како појединачно тако и у смјеши. Сви 
испитивани узорци третирани су на двије различите температуре (25 оC и 70 оC) у 
одређеним временским интервалима (0 минута, 1 h, 24 h, 48 h и 72 h). Као метода за 
праћење процеса деградације коришћена је претходно развијена и валидирана течна 
хроматографија хидрофилних интеракција (енг. Hydrophilic Interaction Liquid 
Chromatography – HILIC). Добијени резултати су показали да је амлодипин-бесилат 
стабилнији у воденом него у киселом медијуму, затим да је стабилнији у смјеши него 
појединачно и да је стабилнији на нижим температурама. Ово је потврђено добије-
ним вриједностима праћених параметара: амлодипин-бесилат Ea = 30,68 кЈ мол-1,  
к (25 °C) = 0,000333 mM h-1, к (70 °C) = 0,00169 mМ h-1; амлодипин-бесилат у смјеши 
Еа = 42,414 кЈ мол-1, к (25 °C) = 1,27 · 10-4 mM h-1, к (70 °C) = 0,0012 mМ h-1. Бисо-
пролол-фумарат је показао изванредну стабилност у односу на медијуме у којима је 
испитиван и добијена је приближна вриједност енергије активације за киселу  
(59 кЈ мол-1) и водену (56 кЈ мол-1) средину. С друге стране, температура је имала 
значајан утицај на стабилност бисопролол-фумарата. Добијени резултати дају реле-
вантне податке о стабилности испитиваних активних супстанци и могу бити од зна-
чаја током развоја одговарајућег фармацеутског производа. Већи утицај на стабил-
ност бисопрoлол-фумарата имаo је температурни ефекат.  
Кључне ријечи: амлодипин-бесилат, бисопролол-фумарат, стабилност у рас-
твору, хемијска кинетика. 
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